US EditionPublished • loading... • Updated
WuXi Biologics Achieves ISO 20400 Certification, Setting Benchmark in Sustainable Procurement
WuXi Biologics integrates sustainability into procurement, managing 864 client projects and advancing climate goals through transparent supplier lifecycle management.
- On Jan. 4, 2026, WuXi Biologics announced it achieved ISO 20400 Sustainable Procurement certification in WUXI, China, an internationally recognized standard promoting supply chain transparency.
- The company adopted an integrated strategy with SBTi targets and refined sustainability strategy and roadmaps to tackle climate change and support sustainable growth, WuXi Biologics said.
- With more than 12,000 skilled employees worldwide, WuXi Biologics operates in China, the United States, Ireland, Germany and Singapore and holds top ESG ratings including MSCI AAA and EcoVadis Platinum.
- The certification strengthens supply‑chain resilience and accelerates sustainable practices among suppliers, supporting responsible value‑chain outcomes and complementing WuXi's 864 integrated client projects including 24 in commercial manufacturing as of June 30, 2025.
- Embedding sustainability in supplier lifecycle management, WuXi Biologics said it manages compliance and risk from due diligence to termination while highlighting ties to PSCI, UNGC, and green technology to position the CRDMO as a procurement benchmark.
Insights by Ground AI
63 Articles
63 Articles
LoudounTimes.com+62 Reposted by 62 other sources
WuXi Biologics Achieves ISO 20400 Certification, Setting Benchmark in Sustainable Procurement
WUXI, China, Jan. 4, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK) announced it has achieved ISO 20400 Sustainable Procurement certification, an internationally recognized standard that integrates sustainability principles into procurement practices and promotes transparency and responsibility across the supply chain. This…
Coverage Details
Total News Sources63
Leaning Left7Leaning Right6Center23Last UpdatedBias Distribution64% Center
Bias Distribution
- 64% of the sources are Center
64% Center
L 19%
C 64%
R 17%
Factuality
To view factuality data please Upgrade to Premium
